Midwest Prostate Urology Health Center

Chicago, Illinois 60640

0 studies enrolling now · 5 studies all time

What they study most

Benign Prostatic Hyperplasia, Metastatic Androgen Independent Prostate Cancer, Prostate Cancer

Studies at this site

• Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442) — Completed
• Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy — Completed
• Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia — Stopped early
• DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2]) — Stopped early
• The Plenaxis® Experience Study — Paused